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Abstract: The alternative splicing of pre-mRNAs expands a single genetic blueprint to encode
multiple, functionally diverse protein isoforms. Viruses have previously been shown to interact with,
depend on, and alter host splicing machinery. The consequences, however, incited by viral infection
on the global alternative slicing (AS) landscape are under-appreciated. Here, we investigated the
transcriptional and alternative splicing profile of neuronal cells infected with a contemporary Puerto
Rican Zika virus (ZIKVPR ) isolate, an isolate of the prototypical Ugandan ZIKV (ZIKVMR ), and dengue
virus 2 (DENV2). Our analyses revealed that ZIKVPR induced significantly more differential changes
in expressed genes compared to ZIKVMR or DENV2, despite all three viruses showing equivalent
infectivity and viral RNA levels. Consistent with the transcriptional profile, ZIKVPR induced a higher
number of alternative splicing events compared to ZIKVMR or DENV2, and gene ontology analyses
highlighted alternative splicing changes in genes associated with mRNA splicing. In summary, we
show that ZIKV affects cellular RNA homeostasis not only at the transcriptional levels but also
through the alternative splicing of cellular transcripts. These findings could provide new molecular
insights into the neuropathologies associated with this virus.
Keywords: Zika virus; Flavivirus; SH-SY5Y; transcriptome; alternative splicing

1. Introduction
Zika virus (ZIKV) is a re-emerging mosquito-borne flavivirus that is classified within the Flaviviridae
family. Other notable flaviviruses include dengue virus (DENV), yellow fever virus (YFV), West Nile
virus (WNV), and tick-borne encephalitis virus (TBEV), all of which are primarily transmitted via
the bite of an infected mosquito or tick [1]. Flavivirus infections rarely result in death, and common
symptoms include a maculopapular rash, a fever, and achy joints [2]. ZIKV was first identified in 1947
in the Zika forest in Uganda [3,4]. Until the early 2000s, only thirteen confirmed ZIKV infections in
humans were reported [5–8]. The first major outbreak of ZIKV occurred in 2007 on Yap Island [9],
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followed by a 2010 outbreak in Cambodia [10], and an outbreak in French Polynesia in 2013 that
resulted in more than 29,000 human infections [11]. This Asian lineage of ZIKV expanded west, and in
2015, efforts were redirected towards understanding the link between ZIKV infection and the associated
neurological pathologies that are now termed Congenital Zika Syndrome (CZS) [12,13]. To date, there
are no antivirals or a licensed vaccine to prevent ZIKV infection. Therefore, to develop effective
therapies and thus limit the symptoms associated with ZIKV infection, it is critical to understand
virus–host interactions and ZIKV pathogenesis.
The striking feature of the 2015 ZIKV outbreak in the Americas was the correlation between
prenatal ZIKV infection and devastating consequences for fetal brain development—resulting in
microcephaly, cortical malformations, and intracranial calcifications [14–17]—and the increased
number of cases of Guillain–Barré syndrome in adults [18–21]. As a first step to elucidating
ZIKV-directed mechanisms resulting in neurological anomalies, studies using in vitro, ex vivo, primary
cell, and in vivo mouse infection models were undertaken. These studies determined that ZIKV infected
neuroepithelial stem cells and radial glia cells, resulted in cell cycle arrest, altered differentiation,
increased cell death, and altered thicknesses of neuronal layers [22–26]. These outcomes at the
cellular level were the result of ZIKV disrupting centrosomes, changing the cell division plane,
inducing apoptosis, and altering signaling pathways [14,22–25,27–29]. At the genetic level, ZIKV
was shown to dysregulate the transcription of cell-cycle, DNA repair, immune response, cell death,
and microcephaly genes [14,22–25,27–29]. Interestingly, differences in the infectivity toward neural
stem cells and other neuronal cell lines of the original ZIKV strain isolated in Uganda in 1947 and
Asian lineage isolates, including those isolated from the 2015 outbreak in the Americas, have been
reported [27,29–35]. Despite these reported infectivity differences, RNA-seq studies showed that the
changes in the transcriptome were less dramatic [14], suggesting that changes in gene expression alone
do not entirely explain ZIKV neuropathologies.
We recently showed that during ZIKV infection, HuR (or ELAVL1) is re-localized from the nucleus
to ZIKV replication sites [36]. Since the ELAVL family of proteins regulate mRNA splicing and
stability [37,38], we posited that the re-localization of certain RNA-binding proteins, such as HuR,
could impact RNA transcription as well as mRNA splicing and stability and thus contribute to the
dysregulation of cellular pathways critical for neuronal development. Indeed, molecular diversity
within the central nervous system is in part the result of alternative splicing events [39]. Studies of
developing cortices in primates [40] and rodents [41] showed variation in alternative exons, and brainor neuron-specific splicing patterns changed dramatically during development [42,43]. Moreover,
the temporal and cell-type specific regulation of alternative splicing (AS) events was largely due to the
recognition of regulatory sequences within pre-mRNA transcripts by RNA-binding proteins (RBPs)
enriched in neurons, such as Rbfox and neuronal ELAVL proteins [39].
In this study, we used RNA-seq to investigate the transcriptional profiles and alternative splicing
events in a neuroblastoma cell line following infection with a modern isolate of ZIKV circulating in
the Americas (PRVABC59; ZIKVPR ), the original 1947 ZIKV isolate from Uganda (MR766; ZIKVMR ),
and DENV2, isolated in Peru in 1996. The analysis of global transcription revealed seven times more
changes in gene expression following infection with ZIKVPR compared to that following infection with
ZIKVMR or DENV2. Moreover, the number of virus-induced alternative splicing events correlated with
the transcriptional profile of each virus infection, where infection with ZIKVPR resulted in many more
alternative splicing events than ZIKVMR or DENV2 infection. Our study highlights an overlooked
impact caused by viral infection on the host and establishes the foundation to further investigate
the impact of specific alternatively spliced genes on neuronal development and the subsequent
neuropathologies observed following ZIKV infection.
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2. Materials and Methods
2.1. Cell Maintenance
SH-SY5Y neuroblastoma cells (ATCC CRL-2266) were cultured at 37 ◦ C with 5% CO2 and
maintained in Eagle’s minimum essential medium (Sigma, St. Louis, MO, USA), F-12 Ham with
NaHCO3 (Sigma), and 10% fetal bovine serum (FBS; Seradigm). Aedes albopictus cells (C6/36; ATCC
CRL-1660) were grown at 27 ◦ C with 5% CO2 and maintained in Eagle’s minimum essential medium
supplemented with 10% FBS, sodium pyruvate (0.055 g/L; Life Technologies, Carlsbad, CA, USA),
Fungizone (125 µg/L; Life Technologies), and penicillin and streptomycin (50,000 units/L penicillin,
0.05 g/L streptomycin; Life Technologies).
2.2. Preparation of Virus Stocks
ZIKVMR (Uganda MR766 strain) was a gift from Dr. Brett Lindenbach (Yale University), and
ZIKVPR (Puerto Rico PRVABC59 strain) was a gift from Dr. Laura Kramer (Wadsworth Center NYDOH)
and the CDC. Aliquots of DENV2 (OBS-2629) isolated in Peru in 1996 were gifted to the Pager laboratory
by Dr. Alexander Ciota (Wadsworth Center NYDOH). To create virus stocks, C6/36 cells were seeded
into 15 cm tissue culture plates or T75 flasks, and the cells were infected near confluence. In particular,
a viral master mix was prepared (5 mL of PBS and 500 µL of virus aliquot per plate), the medium was
aspirated from each plate, and the viral master mix was added to cells. The plate was returned to the
incubator for one hour with rocking every 15 min. After the one-hour incubation, 10 mL of complete
medium was added, and the plate was returned to the 27 ◦ C incubator for seven days. After seven days,
medium was transferred to 50 mL conical tubes, centrifuged at 1000× g for 5 min, and 500 µL aliquots
of the viruses were prepared and stored at −80 ◦ C. To ensure successful infection, 3 mL of TRIzol
reagent was added to the culture plate and RNA was extracted for RT-qPCR analysis. Virus titers were
determined by plaque assays as previously described [27].
2.3. Viral Infections
SH-SY5Y cells were seeded in 6 cm tissue culture plates with 3 mL of complete medium. When cells
neared 90% confluence, a control plate of cells was counted to determine the multiplicity of infection
(moi). SH-SY5Y cells were infected at a moi of 5. Specifically, the appropriate amount of virus was
diluted in PBS to a 1.5 mL total volume, which was then added to each plate. The plates were returned
to the 37 ◦ C incubator for one hour with rocking every 15 min, after which 1.5 mL of complete medium
was added. The cells were harvested at one day post-infection.
2.4. Harvest of Virus-Infected Cells
Cells were harvested by first aspirating the medium from the tissue culture plates, gently washing
the cells with 1 mL of PBS, and lysing the cells in 500 µL of TRIzol reagent (Life Technologies). The cells
in TRIzol were manually scraped and transferred to a 1.5 mL tube, and RNA was extracted following
the manufacturers’ recommendations. Following ethanol cleanup, RNA was resuspended in 20 µL of
Ambion 0.2 µm filtered water.
2.5. Plaque Assays
Viral titers, as determined by plaque assays, for ZIKV were carried out as has previously been
described [36]. Briefly, a monolayer of Vero cells on six-well plates were infected with serial dilutions
of virus prepared in PBS. After a one-hour incubation, a 1:1 overlay (1.2% oxoid agar and modified
DMEM) was added to each well. After solidifying at RT, the plates were returned to the incubator for
4 days. Plaques were developed using 1% crystal violet in 20% methanol. Plaque assays for DENV
were performed with slight modifications. The 1:1 overlay mixture was composed of 2× MEM, 10%
FBS and 1.2% oxoid agar. Additionally, plaques were developed using neutral red staining. One day
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prior to plaque visualization, an additional oxoid agar overlay was prepared by adding 2 mL of neutral
red stock (0.33%) per 100 mL of overlay. The agar was melted, and 3 mL were added to each well.
The plate was left at RT for 10 min for the agar to solidify and then returned to the incubator overnight
for the stain to diffuse into the cells of the monolayer.
2.6. Immunofluorescence Analysis
SH-SY5Y cells were seeded into 24-well plates treated with poly-d-lysine (1 mg/mL; Sigma).
When cells reached 90% confluence, 2 wells were trypsinized and counted to determine the moi.
Similar to infection in the 6 cm tissue culture plates, the SH-SY5Y cells were infected at a moi of 5 in
a total viral master mix volume of 300 µL. One hour after the addition of virus, 600 µL of complete
medium was added to each well. One day post-infection, the cells were washed twice with PBS,
fixed with 4% paraformaldehyde in PBS for 10 min at room temperature, and then permeabilized
with 100% iced methanol for 10 min. The cells were washed at room temperature in blocking buffer
(PBS-1% fish gelatin (FG); Sigma) three times for 15 min. Mouse-anti-J2 dsRNA antibody (Scicons) was
diluted in blocking buffer (1:250 v/v), added to the appropriate wells, and incubated overnight at 4 ◦ C.
Donkey-anti-mouse IgG Alexa Fluor-488 antibody (Invitrogen) diluted in blocking buffer (1:200 v/v)
was added for 1 h at room temperature in the dark. Hoechst-33342 (Life Technologies) was applied for
15 min. Before and after the application of antibodies, the cells were washed with blocking buffer three
times for 15 min. Finally, the cells were washed twice with PBS for 5 min and visualized on the Evos
FL cell imaging system (ThermoFisher Scientific).
2.7. RT-qPCR
To confirm ZIKV and DENV infection prior to the preparation of RNA-seq libraries, RT-qPCR
was performed with virus-specific primers (Table S1), and the amount of viral RNA was determined
relative to β-actin mRNA levels. RNA for each sample (100 ng) and 10 µM forward and reverse primers
were added to the RT-qPCR master mix containing RT enhancer, Hot-Start master mix, and Verso
Enzyme mix (Life Technologies). Reactions were carried out beginning with reverse transcription at
50 ◦ C for 15 min. The RT enzyme was heat-inactivated at 95 ◦ C for 5 min, followed by 35 cycles of 20 s
denaturation at 95 ◦ C, annealing at 60 ◦ C for 30 s, and extension at 72 ◦ C for 1 min.
2.8. Preparation of Libraries for RNA-Seq
RNA-seq analysis libraries were prepared using the NEBNext® Poly(A) Magnetic Isolation
Module (NEB E7490), NEBNext® Ultra™ Directional RNA Library Prep Kit for Illumina® (NEB E7760),
and NEBNext® Multiplex Oligos for Illumina® (NEB E7335S). Three libraries were concurrently
prepared from three independent experiments of mock-, ZIKV- (MR766 and PRVABC59), and
DENV2-infected SH-SY5Y cells. The poly(A) mRNA was isolated via magnetic beads (NEB #E7490)
from the TRIzol-extracted RNA. In brief, RNA (100 ng) was diluted in nuclease-free water to a final
volume of 50 µL, and oligo dT beads in 50 µL of RNA binding buffer were added. Following a 65 ◦ C
incubation for 5 min, samples were cooled to 4 ◦ C, left at room temperature for 5 min, and washed.
Next, 50 µL of Tris buffer was added to each sample, mixed, and incubated at 80 ◦ C for 2 min.
After cooling to room temperature, 50 µL of RNA binding buffer was added and incubated for 5 min.
Beads were washed, the supernatant was aspirated, and mRNA was eluted by the addition of 11.5 µL
of First Strand Synthesis Reaction Buffer and Random Primer Mix. Prior to the synthesis of cDNA,
samples were placed in a thermal cycler set to 94 ◦ C for 15 min to fragment the mRNA, which was
then transferred to a new tube and placed on ice.
First strand cDNA synthesis reactions were assembled according to the manufacturers’
specifications and added to samples, which were placed in a thermal cycler set to 25◦ C for 10 min, 42 ◦ C
for 15 min, 70 ◦ C for 15 min, and a 4 ◦ C hold. Second strand synthesis was assembled as instructed by
the manufacturer, and samples were incubated for one hour at 65 ◦ C. Double-stranded cDNA was
purified using SPRIselect Beads. Briefly, cDNA was incubated with beads at room temperature for

Viruses 2020, 12, 510

5 of 22

5 min, the supernatant was aspirated, and the beads were washed three times with freshly prepared
80% ethanol. After the final wash, beads were air-dried and DNA was eluted by adding 53 µL of
0.1× TE buffer, vortexing, and incubating at room temperature for 2 min, and then the supernatant was
transferred to a new tube.
Adaptor ligation was performed using NEBNext Ultra II End Prep Reaction according to NEB’s
instructions. NEBNext adaptors diluted 5-fold in iced adaptor dilution buffer, ligation enhancer,
and ligation master mix were added to each tube, gently mixed, and incubated at 20 ◦ C for 15 min.
Following the 15-min incubation, the USER Enzyme was added to each reaction, which was incubated
at 37 ◦ C for 15 min. The ligation reactions were purified using SPRIselect beads as described above,
though DNA was eluted in 17 µL of 0.1× TE buffer. The eluted DNA was transferred to a new
tube, and PCR enrichment of the adaptor ligated DNA was performed using NEBNext Multiplex
Oligos for Illumina (Set 1, NEB #E7335). The PCR reaction mix was assembled according to the
manufacturers’ recommendations and placed in a thermal cycler set to the recommended conditions.
Based on the amount of input material, 10 cycles were carried out. PCR reactions were purified using
SPRIselect beads, eluted in 23 µL of 0.1× TE buffer, and transferred to clean tubes. Prior to sequencing,
libraries were checked for purity via a bioanalyzer and RT-PCR. RNA-seq was performed using the
Illumina NextSeq500.
2.9. Bioinformatics Preprocessing
Raw sequencing reads were analyzed for quality using FASTQC [44]. Following quality and
control analysis, raw sequencing reads were aligned back to the hg19 reference genome using STAR [45]
for AS analysis. Post alignment, BAM files were indexed using Samtools [46]. Count tables were
generated with Salmon [47] for differential gene expression (DGE) analysis.
2.10. Differential Gene Expression (DGE) Analysis and Alternative Splicing
DGE analysis was performed using DESeq2 [38]. Genes that exhibited an adjusted P value of less
than or equal to 0.05 were deemed statistically significant. Gene enrichment analysis of the statistically
significant differential gene expression was done with Panther [48]. Heatmaps and Volcano plots were
produced using the Enhanced Volcano [49] and Pheatmap [50] packages, respectively, in R [51].
Differences in splicing between the individual libraries were assessed using replicate multivariate
analysis of transcript splicing (rMATS) [52]. Splicing events were filtered using a custom Python [53]
script utilizing a cutoff of an absolute value of change in Percent Spliced-In (PSI) of greater than or
equal to 0.10 and a false-discovery rate (FDR) of less than or equal to 0.05. Individual events were
visualized using Sashimi plots [54] utilizing the rmats2sashimiplot tool (http://www.mimg.ucla.edu/
faculty/xing/rmats2sashimiplot/).
2.11. Alternative Splicing Analyses
Following cell infection and TRIzol extraction, RNA concentrations were determined using
a Nanodrop, and 500 ng of each sample was used in a reverse transcription with SuperScript IV
(Life Technologies) using random hexamer primers (IDT). Half of the suggested amount of Superscript
was used in these reactions. The cDNA then underwent PCR for 30 cycles using NEB’s 2× Taq Master
Mix and the primer sets listed in Table S1, which were designed for each gene within the exons
flanking the included/excluded exon. The resulting products were then run by Fragment Analyzer
capillary electrophoresis using the DNF905 1-500 base pair kit (Agilent). Quantification was performed
using the following equation: Percent spliced in (PSI) = ((RFU of Inclusion Band)/(RFU Inclusion
Band+RFU Exclusion Band))×100%, where RFU represents Relative Fluorescence Units. Graphs were
made using the GraphPad Prism software, and unpaired t tests were performed in the program to
determine significance.
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2.12. Statistics
For Figure S2a–e, reads were aligned to the hg38 genome using HISAT2, followed by the
quantification of features using FeatureCounts. Transcript counts were used for analysis via
Limma-voom with no gene annotation file. Lowly expressed genes were filtered out based on counts
per million (cpm) values < 1.0 or samples containing 0 genes. Genes were filtered based on a minimum
log2 fold change of 0.5 with a p-value adjusted threshold [55] of 0.05. Finally, genes were normalized
using the TMM method. The job-dependencies used and versions include Bioconductor-limma
(Version 3.34.9), bioconducter-edge (Version 3.20.7), and r-statmod (Version 1.4.30).
2.13. Data Access
The sequencing data from RNA-Seq were deposited in the NCBI GEO and are available under
accession number GEO: GSE149775.
3. Results
3.1. SH-SY5Y Cells are Permissive for Both Zika Virus Isolates and Dengue Virus
Phylogenetic analyses have revealed a divergence of African Zika virus (MR766) into a distinct
Asian ZIKV lineage [56,57]. Notably, the neurological disorders, such as congenital Zika syndrome in
newborns and Guillain–Barré syndrome in adults, have been causally linked to the Asian lineage ZIKV
strain [58]. While changes in the transcriptional landscape have been linked to the neuropathologies
associated with ZIKV infection, the effect of ZIKV on other cellular mRNA pathways is understudied.
Our goal in this study was to investigate the consequence of ZIKV infection for alternative splicing.
To this end, we surveyed the transcriptional and alternative splicing (AS) landscape induced by ZIKV
infection in SH-SY5Y, a neuroblastoma cell line. Because we were interested in deciphering putative
molecular changes contributing to the developmental and neurological anomalies associated with the
2015 ZIKV outbreak, we compared the differences in gene expression and AS resulting from infection
with a modern ZIKV strain isolated in Puerto Rico in 2015 (PRVABC59; ZIKVPR ) [59] to those resulting
from that with the original ZIKV isolate from Uganda (MR766; ZIKVMR ) [3] as well as to those resulting
from that with a flavivirus that is not known to cause neuropathies, namely, a serotype 2 dengue virus
isolate from Peru (DENV2).
We first examined the permissiveness of SH-SY5Y cells to ZIKVPR , ZIKVMR , and DENV2 infection.
In particular, SH-SY5Y cells were infected at a moi of 5, and at 24 h post infection, we examined virus
infection (Figure 1). Specifically, we determined the extent of infection by fixing and processing cells
for immunofluorescence analysis. Using an antibody that specifically detected double-stranded RNA,
an intermediate of flavivirus replication (Figure 1a), we observed that 31% to 40% of all cells were
infected with ZIKVPR , ZIKVMR , and DENV2 (Figure 1b). Analysis of the infectious particles released
into the culture medium by plaque assays showed that ZIKVPR and ZIKVMR produced similar viral
titers in SH-SY5Y cells. Despite DENV2 showing similar levels of virus infection in SH-SY5Y cells,
the number of infectious DENV2 particles released into the medium was lower compared to that
from ZIKV-infections (Figure 1c). We also isolated total RNA and determined the relative abundance
of viral RNA by RT-qPCR. To this end, we used primers specific to each virus and normalized the
Ct values to those obtained for β-actin mRNA in each sample. RT-qPCR revealed no statistically
significant difference in the viral RNA abundance between each virus (Figure 1d). Together, these data
indicate that ZIKVPR , ZIKVMR , and DENV2 show similar infection levels in SH-SY5Y cells. Moreover,
these data demonstrate that SH-SY5Y cells are equally permissive for the different flavivirus infections.
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in cells infected with ZIKVPR, nearly 6- and 8-fold higher compared to ZIKVMR- and DENV2-induced
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to mock. The top 25 GO-terms were divided into five different categories (cellular response, cellular
localization, cell proliferation/growth, immune response, and other) and plotted as pie graphs (Figure 2c).
Interestingly, ZIKVPR induced a greater percentage of genes related to the cellular response compared to
ZIKVMR and DENV (Figure 2c), while ZIKVMR affected cellular genes influencing cellular localization
(Figure 2c). Additionally, DENV2-altered genes were more heavily linked to cell proliferation and
growth compared to those altered by either ZIKV strain. Notably, only ZIKV-infected cells had GO
terms associated with the immune response (Figure 2c). In SH-SY5Y cells infected with ZIKVMR , 6% of
DE genes were categorized under immune response, while 10% of the genes DE in cells infected with
ZIKVPR were immune response genes (Figure 2c).
We also examined the top 10 DE genes from each infection. Notably, the top DE genes in ZIKVPR
infection were all upregulated, while in ZIKVMR - and DENV2-infected cells, the top 10 DE genes were
upregulated and downregulated (Figure S2). Moreover, we observed little-to-no overlap among the
top 10 DE genes between the viruses (Figure S2). Indeed, only HSPA5 abundance was dramatically
and modestly upregulated in ZIKVPR - and ZIKVMR -infected cells, respectively. Three (ATF3, DDIT3,
and HSPA5) of the top 10 genes upregulated in ZIKVPR are involved in the stress response, and two
genes were associated with lipid metabolism (LDLR and SREBF1). Interestingly, three of the top
ten upregulated genes in ZIKVPR were non-coding RNAs (SNHG15, SNHG17, and OLMALINC)
(Figure S2). GO-term analysis outside the top 10 revealed a large number of genes related to ER stress,
protein misfolding, and PERK-mediated apoptosis.
To examine possible links among the top 10 DE genes between each set of virus- and mock-infected
cells, the top 10 DE genes were submitted to STRING, an online platform that is part of the ELIXIR
infrastructure used to compare functional associations between proteins [61]. Connections between
different proteins were only found when comparing ZIKVPR - to mock-infected cells (Supplemental
Figure S2f), and these connected nodes were involved in PERK-mediated apoptosis (Supplemental
Figure S2f). For example, apoptotic activation by PERK occurs when the ATF4/ATF3 complex activates
DDIT3, which in turn activates GADD34 [62]. These data suggest that ZIKVPR impacts the expression
of genes associated with ER stress at multiple nodes.
We next performed GO-term analysis on genes that were differentially upregulated or
downregulated during virus infection. Consistent with earlier transcriptomic studies, ZIKVPR
modulated the levels of genes associated with the cell cycle, the cellular response to DNA damage
and stress, and apoptosis [22–25,63] (Figure 2d,e). Indeed, the “cellular response to stress” was
overrepresented in both upregulated and downregulated genes for ZIKVPR -infected cells (Figure 2d–e).
Of the top five upregulated GO terms, only ZIKV-infected cells had terms linked to developmental
processes (Figure 2d–g), while those genes upregulated in DENV2-infected cells were linked to terms
associated with the cell response, including the response to stress, radiation, and inorganic substances
(Figure 2h–i).
3.3. ZIKVPR Notably Upregulates Immune Response Genes Compared to ZIKVMR and DENV2
Immunofluorescence and viral RNA abundance showed that SH-SY5Y cells were similarly infected
by ZIKVPR , ZIKVMR , and DENV2 (Figure 1). To further understand the biological effect of each virus in
SH-SY5Y cells, we used GO analysis to predict effects on cellular processes. We observed that 651 and
703 genes were upregulated and downregulated, respectively, following ZIKVPR infection (Figure 3a).
By contrast, only 69 and 106, and 47 and 66 genes were upregulated and downregulated following
ZIKVMR and DENV2 infection, respectively (Figure 3a). This differential gene analysis showed only
two genes (HECW2 and SATB1) that were upregulated following infection with all three viruses,
versus nine common genes (ACHE, PIEZO1, ENO3, CDHR1, CCDC24, VCAM1, SLIT1, C4A, and
ZNF321P) that were downregulated (Figure 3a). While 20 upregulated genes were common between
the ZIKV isolates and 34 genes were similarly upregulated between ZIKVPR and DENV2, ZIKVMR and
DENV2 shared no common genes.
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that were differentially upregulated (top) or downregulated (bottom). DE transcripts from ZIKVPR ,
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50 statistically significant differentially expressed immune response genes in ZIKVPR -infected cells
50 statistically significant differentially expressed immune response genes in ZIKVPR-infected cells
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compared to mock. The expression of these genes in ZIKVMR and DENV2-infected SH-SY5Y cells is
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In ZIKV-infected cells, ICAM1 and VCAM1 were upregulated, but they were downregulated in
DENV2-infected cells (Figure 3b). ICAM1 and VCAM1 are involved in immune cell migration across
the blood–brain barrier [66,67], where an increase in immune cells in the brain might contribute to the
neuropathogenesis associated with intrauterine ZIKV infection. ZIKV and other flaviviruses heavily
depend on the secretory pathway for the maturation of viral progeny. It is, therefore, interesting that
of the 50 significantly altered genes associated with the immune response in Figure 3b, 21 contained
endoplasmic reticulum (ER)-related, Golgi-related, and/or plasma-membrane-related GO cellular
component terms within the top five. These findings show that ZIKVPR -induced changes in gene
expression significantly alter the levels of genes involved in both the immune response and proper
cellular development.
When we compared ZIKVPR versus DENV2 DE genes, 138 genes associated with apoptotic
signaling were downregulated (Figure S3d). Similarly, 23 apoptotic signaling pathway genes were
downregulated when comparing ZIKVPR to ZIKVMR , suggesting that the modern isolate of ZIKV has
developed strategies to usurp antiviral pathways, allowing for the suppression of the host immune
response (Figure S3b). Interestingly, ZIKVMR infection resulted in an upregulation of apoptotic genes
when compared to DENV2 (Figure S3e).
3.4. Exon Skipping is a Major Splicing Event during ZIKVPR , ZIKVMR , and DENV2 Infection
While previous transcriptomic studies have been undertaken during ZIKV infection [22–26],
we were interested in changes in alternative splicing (AS) induced following flavivirus infection.
The splicing of pre-mRNAs can be separated into five major categories, namely, skipped exons (SE),
alternative 50 or 3’ splice sites, mutually exclusive exons, and the retention of introns (Figure 4a).
AS defects resulting in disease can occur when sequences in the pre-mRNA required for correct splicing
are mutated or when regulatory factors essential for splicing are mutated [68]. These two scenarios
can result in missplicing and thus a reduction in the functional protein product or an imbalanced
production of mature mRNA isoforms that contribute to disease.
To analyze splicing events, sequences were aligned to the reference human genome hg19 using
STAR with ~93% of reads aligning uniquely in each library. Using rMATs to analyze splice variants,
a list of ~77,000 (~55,000 SE events) potential AS events occurring in all replicates was generated.
To reduce false-positive splicing events, all AS events with a false discovery rate (FDR) greater than 0.05
and a change in percent spliced in (∆PSI) of less than 0.1 were omitted (~500–1500 events, depending on
libraries). In examining alternative spliced products, we observed that 114 events were shared between
both ZIKV isolates and that eighteen AS events were shared between ZIKVPR and DENV2-infected
cells (Figure 4b). Similarly to the differential gene expression analysis, infection with the modern
Asian-American ZIKVPR isolate resulted in over 2.5 times more AS events compared to cells infected
with ZIKVMR or DENV2 (Figure 4c). When analyzing the types of AS event between each virus
compared to mock, we observed that skipped exons accounted for 63%, 53%, and 46% of all significant
AS events for ZIKVPR , ZIKVMR , and DENV2, respectively (Figure 4c). The second most prevalent AS
event for all infections compared to mock was intron retention (Figure 4c). In DENV2-infected cells,
over 30% of AS events were retained introns, while this AS splicing event was lower—at 21% and 14%,
respectively—in ZIKVMR and ZIKVPR infected cells (Figure 4b). Interestingly, AS events unique to
DENV infection revealed more mutually exclusive exon splicing (16%) compared to the 7% and 5% in
ZIKVPR and ZIKVMR , respectively (Figure 4c).
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all significant categories between viral infections, similarities were only found between ZIKVMR and
DENV2-infected cells, which included monosaccharide transport, the cellular response to nitrogen
compounds, and the regulation of the establishment of protein localization (Figure S5b,c). Moreover,
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found in cells infected with ZIKVPR (Figure S5a).

Figure 4. Analysis of alternative splicing events in virus versus mock-infected SH-SY5Y cells.
Figure 4. Analysis of alternative splicing events in virus versus mock-infected SH-SY5Y cells. (A)
(A) Schematic illustrating the five alternative splice events characterized in our analyses. The unchanged
Schematic
illustrating
alternativespliced
splice events
characterized
in our
The unchanged
exons
are black,
while the
thefive
differentially
exons are
color coded.
(B) analyses.
Venn diagram
of shared
exons
are
black,
while
the
differentially
spliced
exons
are
color
coded.
(B)
Venn
diagram
of shared
and unique genes that were alternatively spliced between virus and mock-infected cells. Alternative
and unique
genes that
alternatively
spliced
between
virusmock,
and mock-infected
cells. Alternative
PR versus mock,
MR versus
slicing
(AS) events
fromwere
ZIKV
ZIKV
and DENV2 versus
mock are
PR versus mock, ZIKVMR versus mock, and DENV2 versus mock are
slicing
(AS)
events
from
ZIKV
highlighted in the red, blue, and yellow circles respectively. (C) Pie charts depicting the percentages
highlighted
theevents
red, blue,
andthree
yellow
circlesversus
respectively.
(C) Pie charts
depicting
of
all uniqueinAS
for the
viruses
mock-infected
SH-SY5Y
cells. the
(D)percentages
Pie charts
of
all
unique
AS
events
for
the
three
viruses
versus
mock-infected
SH-SY5Y
cells.
(D) Pie charts
representing the percentages of each type of AS event unique to each virus infection in SH-SY5Y
cells.
representing
the percentages
of each
type
of AS event
unique
to each
infection
in SH-SY5Y
cells.
The
segment colors
match the AS
events
illustrated
in (A).
Values
in (B)virus
account
for unique
genes while
The
segment
colors
match
the
AS
events
illustrated
in
(A).
Values
in
(B)
account
for
unique
genes
(C) represents all unique splicing events.
while (C) represents all unique splicing events.

In examining which genes were misspliced in each infection compared to in mock-infected
We were
in which
genes
were
uniquely misspliced
eachPR
infection.
SH-SY5Y
cells,interested
we observed
968 genes
were
alternatively
spliced ininZIKV
-infectedUpon
cells, separating
compared
MR
all375
ASand
events
specific
viral condition, we
observed
635 (Figure
genes were
spliced in
to
94 for
ZIKV to -each
and DENV2-infected
cells,
respectively
4b,c).alternatively
To further understand
PR-infected cells, compared to 171 and 32 for ZIKVMR- and DENV2-infected cells, respectively
ZIKV
the biological processes modulated by AS and virus infection, all AS events for each condition
(Figure 4d).
ascertain whether
certain
cellularfor
pathways
were
preferentially
being(Figure
misspliced,
all
compared
toTo
mock-infected
cells were
analyzed
functional
category
enrichment
S5a–c).
PR
unique
AS 10
events
in each significant
viral infection
were analyzed
for enriched
enriched in
GOcells
categories.
the top,
Of
the top
statistically
functional
categories
infectedEach
withofZIKV
PR-specific AS events were linked to RNA processing, with six of the ten
10
enriched
terms
for
ZIKV
four were involved in splicing, providing further support for the observed changes in the global
MR-unique AS events were strongly linked to
being associated
splicing
(Figure
S5d). ZIKVbetween
splicing
landscapewith
(Figure
S5a).terms
A second
commonality
the top 10 functional categories was
fatty acid
metabolism
and of
apoptotic
while the majority
of organelles,
events resulting
from DENV2
related
to the
disassembly
variouspathways,
cellular components
including
ribonucleoprotein
infection
related
to
the
nervous
system
(Figure
S5e
and
S5f).
complexes, and ribosomes (Figure S5a). It is possible that the modern Asian-American ZIKV isolate
To validate
AS events,ofwe
selected
1) transcripts
thatwould
were misspliced
in ZIKV
- compared
to
promotes
the disassembly
specific
cellular
factors that
normally limit
thePRviral
life cycle.
MR
ZIKV
and
DENV2-infected
cells,
and
2)
exon
inclusion/exclusion
events,
as
these
comprised
the
Finally, we observed a significant enrichment in AS genes associated with central nervous system
MR , to
majority of AS
changes
could
be easily
with
RT-PCR.
The with
genesZIKV
chosen
validate
the
myelination
(Figure
S5a).and
When
analyzing
theassessed
AS events
during
infection
only
eight GO
functional categories were statistically significant (Figure S5b). Of these, three were related to protein
localization, two of which were involved in nuclear import and export (Figure S5b). Nine significantly
enriched categories were found in DENV2-infected cells (Figure 5c). When comparing all significant

from mock- and ZIKVPR-infected SH-SY5Y cells (Figure S6). The genes that were functionally of
interest and chosen for validation include: SLC35B3, MFSD8, CHID1, MPRIP, KIF21A, SRSF2,
HNRNPDL, and RBM39. HNRNPDL and RBM39 function in transcriptional regulation [69,70],
HNRNPDL and SRSF2 regulate alternative splicing [69,71], MPRIP is involved in stress granule
Viruses
2020, 12,[62],
510 CHID1 has a role in pathogen sensing [72], and KIF21A has been implicated
13 of 22
formation
in
neurological diseases [73]. Consistent with the selection criterion, most AS events chosen to be
validated via RT-PCR strongly agreed with our RNA-seq data (Figure S7). MR
These data indicate that
categories
between viral infections, similarities were only found between ZIKV and DENV2-infected
PR
ZIKV infection results in significant missplicing, with the greatest difference in PSI values between
cells, which included
monosaccharide transport, the cellular response to nitrogen compounds, and the
mock and ZIKVPR being ~28% (RBM39). For each of the genes examined, we observed no significant
regulation of the establishmentMR
of protein localization (Figure S5b,c). Moreover, the only significantly
splicing changes in the ZIKV -infected cells when compared to the mock infection. Interestingly,
enriched functional category strictly specific to the central nervous system was found in cells infected
however, in DENV2 infection, we determined small but significantly different changes in exon
with ZIKVPR (Figure S5a).
inclusion/exclusion levels in CHID1, SRSF2, HNRNPDL, and RBM39 (Figure 5).

PR -, MR
MRDENV2PR-, ZIKV
Figure 5.5. Validation
alternative
splicing
events
in mock-,
ZIKVZIKV
-, and
Figure
Validationofofselect
select
alternative
splicing
events
in mock-,
ZIKV
-, and
DENV2-infected
SH-SY5Y
cells.RNA
(A–H)
RNA
each
of biological
the three biological
replicates
was
used
infected SH-SY5Y
cells. (A–H)
from
eachfrom
of the
three
replicates was
used for
RT-PCR
for
for thegene.
indicated
gene. The
percent
spliced
(PSI) was
described
in the
forRT-PCR
the indicated
The percent
spliced
in (PSI)
was in
calculated
ascalculated
described as
in the
Materials
and
Materials
change
in the
of aexon.
regulated
exon. The significance
Methods.and
PSIMethods.
indicatesPSI
theindicates
change inthe
the
inclusion
ofinclusion
a regulated
The significance
of the data
ofwas
thedetermined
data was determined
three independent
experiments
using the GraphPad
software
and
from threefrom
independent
experiments
using the GraphPad
software and
performing
performing
an
unpaired
Student’s
t-test;
n.s.
denotes
not
significant,
*
p
<
0.05,
**
p
<
0.01,
***
p
<
0.001,
an unpaired Student’s t-test; n.s. denotes not significant, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p
and
**** p <Figure
0.0001.S6Figure
shows
the corresponding
schematics
of theexons
gene exons
examined
asas
well
< 0.0001.
showsS6the
corresponding
schematics
of the gene
examined
as well
the
asRT-PCR
the RT-PCR
products
Sashimi
plots
genes
analyzedininthis
this figure.
figure. Figure S7
products
and and
Sashimi
plots
for for
thethe
genes
analyzed
S7 shows
showsthe
the
correlation
correlationbetween
betweenthe
thePSI
PSIvalues
valuesobtained
obtainedfrom
fromRNA-seq
RNA-seqand
andRT-PCR.
RT-PCR.

We were interested in which genes were uniquely misspliced in each infection. Upon separating
all AS events specific to each viral condition, we observed 635 genes were alternatively spliced in
ZIKVPR -infected cells, compared to 171 and 32 for ZIKVMR - and DENV2-infected cells, respectively
(Figure 4d). To ascertain whether certain cellular pathways were preferentially being misspliced,
all unique AS events in each viral infection were analyzed for enriched GO categories. Each of the top
10 enriched terms for ZIKVPR -specific AS events were linked to RNA processing, with six of the ten
being associated with splicing terms (Figure S5d). ZIKVMR -unique AS events were strongly linked to
fatty acid metabolism and apoptotic pathways, while the majority of events resulting from DENV2
infection related to the nervous system (Figure S5e,f).
To validate AS events, we selected 1) transcripts that were misspliced in ZIKVPR - compared to
ZIKVMR - and DENV2-infected cells, and 2) exon inclusion/exclusion events, as these comprised the

Viruses 2020, 12, 510

14 of 22

majority of AS changes and could be easily assessed with RT-PCR. The genes chosen to validate the AS
events were selected based on the lowest false discovery rate (FDR) and the highest read count from
the RNA-seq data. RT-PCR was used to compare percent spliced in (PSI) values for the chosen events.
RT-PCR products were analyzed, and the intensity of the splicing products was quantified (Figure S6).
Thus, if virus infection promoted the inclusion of the exon, the PSI value increased. Conversely, if the
exon was excluded during virus infection, the PSI value decreased. Moreover, we show Sashimi
plots, which illustrate the differences in the splice junctions of the selected transcripts from mock- and
ZIKVPR -infected SH-SY5Y cells (Figure S6). The genes that were functionally of interest and chosen
for validation include: SLC35B3, MFSD8, CHID1, MPRIP, KIF21A, SRSF2, HNRNPDL, and RBM39.
HNRNPDL and RBM39 function in transcriptional regulation [69,70], HNRNPDL and SRSF2 regulate
alternative splicing [69,71], MPRIP is involved in stress granule formation [62], CHID1 has a role in
pathogen sensing [72], and KIF21A has been implicated in neurological diseases [73]. Consistent with
the selection criterion, most AS events chosen to be validated via RT-PCR strongly agreed with our
RNA-seq data (Figure S7). These data indicate that ZIKVPR infection results in significant missplicing,
with the greatest difference in PSI values between mock and ZIKVPR being ~28% (RBM39). For each of
the genes examined, we observed no significant splicing changes in the ZIKVMR -infected cells when
compared to the mock infection. Interestingly, however, in DENV2 infection, we determined small but
significantly different changes in exon inclusion/exclusion levels in CHID1, SRSF2, HNRNPDL, and
RBM39 (Figure 5).
4. Discussion
Here we report on the consequence of ZIKV infection for alternative splicing, an element of cellular
RNA homeostasis that is understudied in virus–host interactions. ZIKV has garnered worldwide
attention due to the increased incidence of developmental and neurological defects in newborns
following intrauterine infection [12,13]. RNA-seq studies in neuronal cells revealed the transcriptional
dysregulation of genes associated with cell-cycle, DNA repair, the immune response, cell death,
and microcephaly [23,24,27–29,35]. To investigate alternative splicing in neuronal cells, we sought
a human cell culture line that would model ZIKV infection in neurons. To this end we used the
neuroblastoma cell line SH-SY5Y, which has previously been used to investigate virus–host interactions
with different neurotropic viruses such as poliovirus [74], enterovirus D68 [75], herpes viruses [76–78],
and Japanese encephalitis virus [79]. We observed that the infection of SH-SY5Y cells with the two
different ZIKV strains and DENV2 for 24 h at a moi of 5 resulted in similar levels of viral RNA and
infectious viral particles (Figure 1c,d). Initial studies examining gene dysregulation following ZIKV
infection were undertaken in human neural stem cells (hNSCs) [30,31], human neural progenitor
cells (hNPs) [27,32], organotypic cultures [29,33], neurospheres [34], and cerebral organoids [35].
These studies used different ZIKV strains, multiplicities of infection, and lengths of infection, and thus
the extent of ZIKV infection ranged from 2.5% to 90% [27,29–35]. Consistent with earlier reports
of ZIKV infection in SH-SY5Y cells [80,81], immunofluorescence analyses revealed that 40% of cells
were infected (Figure 1a,b). While we recognized that the differential gene expression and alternative
splicing analyses collected would be on a modest number of infected cells, we reasoned that this level
of infection would be comparable to the previous transcriptome-wide studies [27,29–35] and that, thus,
changes in the alternative splicing landscape would model such changes in ZIKV-infected neurons.
Our RNA-seq studies demonstrated that in SH-SY5Y cells, ZIKVPR alters the transcriptional
landscape more than either ZIKVMR or DENV2 (Figure 2b). GO term analyses of the differentially
expressed genes showed that during ZIKV but not DENV2 infection, innate immune response
genes were modulated (Figure 2c). In primary human skin fibroblasts, the French Polynesia ZIKV
isolate (ZIKVFP ) promoted the transcription of RIG-I (DDX58), MDA5 (IFIH1), and TLR3, as well
as interferon-stimulated genes such as OAS2, ISG15, and MX1 [82]. We similarly found that RIG-I
(DDX58) and MDA5 (IFIH1) were upregulated by both ZIKV isolates, but not by DENV2 (Figure S4).
The 20 ,50 -oligoadenylate synthase (OAS) and RNase L pathways have previously been shown to
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restrict flavivirus infection [83–85], yet in ZIKVPR -infected SH-SY5Y cells, we observed that OAS3 was
downregulated (Figure S4), while OASL was notably upregulated (Figure 3b). OASL was previously
shown to have antiviral activity mediated through RIG-I activation [73]. It is therefore possible that
in neuronal cells, ZIKV gene expression is restricted by a RIG-I-OASL-linked and/or MDA5 (IFIH1)
pathway. We also found that NF-kB inflammatory response genes including BIRC3, NFKBIA, REL, and
CXCL10 were upregulated in ZIKVPR -infected cells (Figure 3). These genes were similarly upregulated
in ZIKV-infected human neural progenitor cells [86] and primary human skin fibroblasts infected
with ZIKVFP [82], although Simonin et al., reported that in human primary neuronal cells infected
with an Asian ZIKV strain, NF-kB genes were downregulated [30]. Overall, our RNA-seq analyses
of ZIKV-infected SH-SY5Y cells show similar transcriptional changes in cellular processes to studies
in organoids and neural stem and progenitor cells. The differences between studies of differentially
expressed genes might in part be due to the infection system, variability in infection levels, and ZIKV
isolates used.
We posited that in addition to altering gene expression, ZIKV infection would also impact
alternative splicing. Notably, herpes viruses, adenovirus, and influenza A virus subvert the cellular
RNA splicing machinery to broaden the coding capabilities of the viral genome [87–89], and Sindbis
virus has been shown to alter the polyadenylation and splicing of select cellular mRNAs by sequestering
cellular RNA binding proteins involved in these processes [38]. Although flaviviruses do not splice
their own RNA genomes, DENV2 RNA-dependent RNA polymerase (NS5) has been shown to localize
in the nucleus and bind to and interfere with the mRNA splicing of multiple antiviral factors [90]. Here,
we identified 968 and 375 AS events in ZIKVPR - and ZIKVMR -infected cells, respectively (Figure 4b).
The skipping of an exon cassette is the most common type of AS in humans [91,92]. Indeed, following
infection with all three viruses, our analyses revealed that exon skipping accounted for the majority
(45–63%) of all AS events (Figure 4a–c). Thirteen percent of splicing reactions used an alternative
30 splice site in ZIKVMR -infected cells, compared to 7% and 6% in ZIKVPR - and DENV2-infected
SH-SY5Y cells, respectively (Figure 4c). In reovirus-infected cells, alternative 30 splice site event
selection occurred in 24% [93]. Of the different types of AS we analyzed, 14% of the AS events in
ZIKVPR -infected cells were intron-retention. In reovirus-infected cells, intron retention accounted
for just 10% of AS types [93]. While intron retention was initially thought to be the least prevalent
form of AS in animals, Braunschweig et al. (2014) reported that intron retention was a frequent
occurrence and that this mode of AS functioned to broadly reduce the levels of transcripts that were
not required for cellular homeostasis [94]. In ZIKVMR - and DENV2-infected cells, 21% and 31% of AS
events were via intron retention (Figure 4c). It would be interesting to investigate the turnover rate
of the intron-retained transcripts in ZIKVMR - and DENV2-infected cells and compare these with the
intron-retained transcripts in ZIKVPR -infection. One intriguing possibility is that the change in RNA
stability might limit the effect of ZIKVMR and DENV2 on neuropathogenesis.
Since ZIKVPR infection resulted in the highest number of AS transcripts and that many of these
were categorized within mRNA splicing-related processes (Figure S5), we focused our validation on
AS events arising during ZIKVPR infection. We specifically validated SLC35B6, MFSD8, CHID1, MPRIP,
KIF21A, SRSF2, HNRNPDL, and RBM35. These genes were of particular interest as alternative splicing
could influence ZIKV infection and/or neuron development or function. For example, the alternative
splicing of SLC35B6, MFSD8, and CHID1 might affect ZIKV infection. ZIKV enters the cells by
receptor-mediated endocytosis, where membrane fusion of the viral envelope is triggered by low pH
and the glycosylated envelope proteins [1]. SLC35B3 localizes primarily to the ER and Golgi and
is a 30 -phophoadenosine 50 -phosphosulfate transporter involved in sulfation [95], and MFS domain
containing 8 (MFSD8), also known as CLN7, encodes a ubiquitously expressed putative lysosomal
transporter [96]. Thus, the alternative splicing of SLC35B6 and MFSD8 might alter functions within
the endomembrane system and affect ZIKV entry and/or egress. Interestingly, mutations in CLN7
have been linked to a group of autosomal recessive neurodegenerative diseases known as neuronal
ceroid lipofuscinoses (NCLs) [97]. Last, Chitinase Containing Domain protein 1 (CHID1) encodes a
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protein belonging to the superfamily glycoside hydrolase family 18 (GH18) and may have a role in
carbohydrate binding [72]. CHID1 has been shown to bind lipopolysaccharide (LPS), suggesting this
protein plays roles in pathogen sensing [72]. It is possible that the exon exclusion event occurring
in ZIKVPR -infected cells (Figure 5c) specifically targets a domain required for pathogen sensing to
promote or limit infection.
Myosin phosphatase-Rho interacting protein (MPRIP) targets myosin phosphatase to the actin
cytoskeleton and is required for the regulation of actin by RhoA and ROCK1 [98]. Curiously, MPRIP
overexpression has been shown to disassemble stress granules (SGs) in neuronal cells [99]. In addition
to the increased exclusion of exon 23 (Figure 5d), our transcriptomic studies revealed an increased
expression of MPRIP only in ZIKVPR -infected cells. ZIKV disrupts the formation of sodium
arsenite-induced SGs in neuronal and non-neuronal cells [36,100], and we have shown that specific
SG components exhibit both proviral and antiviral functions [36]. While the exact composition of
neuronal SGs is not known, perhaps different MPRIP isoforms differentially modulate the formation of
neuronal SGs, which would impact ZIKV gene expression. We also showed that ZIKVPR infection
led to the increased exclusion of exon 27 in KIF21A (Figure 5e). KIF21A is a member of the KIF4
subfamily of kinesin-like motor proteins that has been shown to affect axon and growth cone
morphology [73], presenting the possibility that the alternative splicing of KIF21A as a result of ZIKV
infection influences neurodevelopment.
SRSF proteins constitute a large portion of the spliceosome, contain RNA recognition motifs
(RRMs), and also play a role in the export of mRNA from the nucleus [101]. Our analyses showed
that SRSF2, SRSF3, SRSF6, and SRSF7 were alternatively spliced in ZIKVPR -infected cells but not
in ZIKVMR -infected cells. HNRNPDL (JKTBP1) is a paralog of HNRNPD (AUF1), which has been
shown to be important for transcriptional regulation and alternative splicing via binding to AU-rich
sequences [69]. Hu et al. similarly reported that HNRNPDL was alternatively spliced in ZIKVPR -infected
cortical neural progenitor cells [102]. The inclusion of exon 8 targets HNRNPDL for nonsense-mediated
decay (NMD) [103], presenting the possibility that by promoting exon 8 inclusion (Figure 5g), ZIKVPR
infection targets HNRNPDL for degradation. Lastly, the downregulation of the splicing factor RNA
binding motif protein 39 (RBM39) decreases the expression of cell-cycle progression regulators. Since
ZIKV has been shown to affect the cell cycle [23,27], it would be interesting to determine how the
alternative splicing of RBM39 contributes to this process (Figure 5h). As it modulates the exon
incorporation/skipping of SRSF2, HNRNPDL, and RBM39 alone, it is not surprising that ZIKVPR
changed the global alternative splicing landscape in infected cells (Figure 5f–h, and Figure S5f–h),
a change that could significantly impact the infectious cycle and pathogenesis.
Gene levels change dramatically during brain development. Such changes are not just directed by
transcript levels but also by alternative splicing, which can expand the proteome. Moreover, alternative
splicing may influence RNA stability, the efficiency of translation, and localization. It is therefore hardly
surprising that alternative splicing is intimately involved in neurodevelopment and synaptic plasticity.
Devastating congenital abnormalities and neurological complications were linked to infection during
the recent ZIKV outbreak [12,13], and transcriptome-wide studies have provided initial insight into
the molecular neuropathogenesis of ZIKV [14,22–25,27–29]. Here, we demonstrate that changes in
gene expression are not the only effect ZIKV has on cellular RNA homeostasis, but that ZIKV also
modulates alternative splicing events. By identifying and validating AS events resulting from ZIKVPR ,
we have established the foundation for future studies to dissect the biological impact of ZIKV-induced
changes to the alternative splicing landscape and neurodevelopment.
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